U.S. markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
73.61+0.56 (+0.77%)
At close: 4:02PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close73.05
Open73.59
Bid73.62 x 1100
Ask73.73 x 1100
Day's Range73.40 - 74.63
52 Week Range68.44 - 81.68
Volume14,714,660
Avg. Volume10,516,356
Market Cap186.334B
Beta (5Y Monthly)0.42
PE Ratio (TTM)33.52
EPS (TTM)2.20
Earnings DateOct 28, 2021
Forward Dividend & Yield2.60 (3.53%)
Ex-Dividend DateSep 14, 2021
1y Target Est92.42
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    12 days agoMorningstar
View more